Catherine Skobe shares her insights on innovation in medical communications including creative approaches to increasing patient engagement and involvement in scientific publications.
Read about new guidance from the PMCPA that aims to ensure the social media activities of pharmaceutical companies stay within the law.
Valérie Philippon shares her perspectives on the value of including data beyond those generated in clinical trials in publication plans.
Braydon McCormick and Mark Handforth discuss collecting meaningful data about meetings.
Antonia Trent and James Atherton discuss recent changes in the HCP engagement landscape.
Learn about a new decision support tool developed to supplement the ICMJE criteria and GPP3 guidelines.
New study maps ties between the medical product industry and healthcare ecosystem, exposing regulatory and transparency issues.
How can pharma unlock the potential of social media? A recent article from EMWA’s Medical Writing journal discusses potential applications.
Read about their call to action for the pharmaceutical industry to increase sharing of clinical trial data.
Creators of Industry Voice share tips on how to leverage video content to generate discussion among experts, engage viewers, and build brand value.
Medical Publishing Insights and Practices (MPIP) initiative members share perspectives on the benefits of publishing industry-sponsored research open access.
Find out why financial relationships are not always correctly disclosed and how better transparency could be achieved.
A recent study published in BMC Medicine audits data sharing from pharmaceutical industry-sponsored clinical studies.
As the drive towards open access continues, pharmaceutical company Shire announced a new policy of mandatory open access publication of company-sponsored research.